Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis.
about
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenibRaf family kinases: old dogs have learned new tricksDirect interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growthRit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascadesRaf-1: a novel cardiac troponin T kinaseScaffold Proteins Regulating Extracellular Regulated Kinase Function in Cardiac Hypertrophy and DiseaseWhat links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatmentSignaling effectors underlying pathologic growth and remodeling of the heartThe potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shockThe case for inhibiting p38 mitogen-activated protein kinase in heart failureMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signalingAnti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis ModelRegulation and role of Raf-1/B-Raf heterodimerization.Pancreatic β-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcriptionCancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.RAF kinase activity regulates neuroepithelial cell proliferation and neuronal progenitor cell differentiation during early inner ear development.Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case DiscussionSorafenib cardiotoxicity increases mortality after myocardial infarction.Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning.Calpain protects the heart from hemodynamic stress.Mitochondrial DNA that escapes from autophagy causes inflammation and heart failureCrosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesEssential role of B-Raf in ERK activation during extraembryonic developmentInhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.Redox signaling and cardiac sarcomeresAnthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in caninesPhysiological, pharmacological and toxicological considerations of drug-induced structural cardiac injuryCardiovascular safety of VEGF-targeting therapies: current evidence and handling strategiesERK signaling, but not c-Raf, is required for gonadotropin-releasing hormone (GnRH)-induced regulation of Nur77 in pituitary gonadotropesGab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling.mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.Raf kinases: function, regulation and role in human cancer.Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutantsProtein kinases of the Hippo pathway: regulation and substrates.Novel roles of PAK1 in the heart.Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway.
P2860
Q21261282-315D4CB7-F92B-4F28-932B-A52286398A3BQ24316181-80DCA5C8-FDA7-42AD-88AE-188D4A2D65D9Q24322716-E8C7CB30-C332-415A-AD55-0BA21A052B2DQ24557569-ACA2E53B-E8A9-4CBC-AF8D-DC70309E775BQ24626540-13EB384A-BBD3-4F72-BCB6-7C7550EBC186Q26765993-F8F8BF0D-0BDA-4096-92E1-42CDEC664C66Q26782585-379E32EC-9560-4165-9671-E1BDAE026485Q26825154-E216FF8B-D72D-4C0A-B57C-A971990A9C47Q27024163-1CF6B7E8-6BA4-4E69-BF57-9A3D1F90BB29Q28080674-EEED705D-4350-4B0C-A67C-21A25DE4164DQ28296128-AC47CA5C-47E2-4962-AAE1-ADB0711B2DF8Q28504557-33277F3D-5B74-4A5D-9BA1-B3D698B04DEEQ28555141-86C5C176-B0F6-4DC1-BA91-49901C364BEEQ28580581-CB11FEEB-E191-4268-8EB2-1306248975A6Q28586031-FD788C72-1170-49F1-88FF-BB3B5E381BEEQ30426853-ECA391F6-54A2-42ED-8E15-CB60328628E9Q30477716-7C3A6F99-B345-4053-90CB-D01227ADB15AQ33659820-3F012729-2399-4AE1-B991-05C9BB562266Q33681995-642148A1-6C13-42C1-977C-FEBAE411D8CEQ33714000-1DDF73F4-70E6-479F-AAA3-826446D23DB5Q33807542-61520D2E-F747-4AE0-80E8-4604906314B5Q33959183-6EFCA9F9-F146-4080-B93F-0CD7C7EDC3E4Q33973418-71765D15-12AF-45D9-8156-5918F4ABD64BQ34270939-C75512AE-8F5F-4E7E-8BA6-E8150972A69FQ34289211-B1E2CA81-539B-4751-8109-DC6EADA5FB35Q34334827-9E8730D8-054F-462F-9396-9A1023C468FDQ34512913-564C67E0-EF0A-4BD9-8158-771E37D60795Q34696170-F5471F37-A702-4C8D-AB60-AFE00FDFB5F5Q34701752-5AD45F47-7D7F-4DA3-AEA3-A75FF7DF3020Q35039202-CC84CF24-81AD-4E19-B028-DB9F26509A85Q35584182-5F968D9E-06F2-4525-80A5-7A5E5A6929C5Q35744552-FDF05D61-4D12-46C1-B6D7-3EA7357821F6Q35836843-B872D121-CA96-4631-8FF7-7C52DBC87878Q35972916-7975966E-0D68-4CE1-982C-99D023C5A200Q36002845-4CB6C202-2563-4DEA-85C4-4AD2B331166FQ36277286-3D485FAE-2B86-422C-917B-D7226C0B0D3BQ36371333-D40DE2F6-5AC0-47E7-AEAF-9CEE689501F1Q36376815-35A0120B-11E7-42A4-8A08-75A191C7814AQ36469606-BB6A5340-51FD-4C45-AB53-C8B4714F258BQ36685199-E853F91B-4512-468A-A85A-4205623BD06D
P2860
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cardiac-specific disruption of ...... iac dysfunction and apoptosis.
@en
type
label
Cardiac-specific disruption of ...... iac dysfunction and apoptosis.
@en
prefLabel
Cardiac-specific disruption of ...... iac dysfunction and apoptosis.
@en
P2093
P2860
P356
P1476
Cardiac-specific disruption of ...... iac dysfunction and apoptosis.
@en
P2093
Atsuko Nakai
Atsushi Matsuzawa
Chiharu Sadamitsu
Ikuko Tsujimoto
Jun-ichi Miyazaki
Kazuhiko Nishida
Kazunori Kashiwase
Kenneth R Chien
Kinya Otsu
Masatsugu Hori
P2860
P304
P356
10.1172/JCI20317
P407
P577
2004-10-01T00:00:00Z